Payne C R, Hadfield J W, Stovin P G, Barker V, Heard B E, Stark J E
J Clin Pathol. 1981 Jul;34(7):773-8. doi: 10.1136/jcp.34.7.773.
The accuracy of diagnosis in 656 patients with the four common histopathological types of primary lung cancer has been assessed by comparing the cell type diagnosis made on cytological and histological investigation with that determined by examination of the surgically resected or necroscopy specimen. The accuracy of diagnosis achieved by cytological examination of sputum and bronchial aspirate, and by bronchial biopsy histology was over 85%. The least accurate diagnostic procedure was percutaneous needle biopsy (62%). Squamous and small cell tumours were accurately diagnosed by all four investigations but errors were made in the diagnosis of large cell and adenocarcinomas. Nearly half the number of patients (43%) with large cell carcinoma were later reclassified as having squamous carcinoma and of the patients with adenocarcinoma 32% had been predicted to be squamous and 18% large cell carcinoma. We consider such quality control of pretreatment diagnosis mandatory in management of individual patients and before enrollment in clinical trials.
通过将细胞学和组织学检查得出的细胞类型诊断结果与手术切除标本或尸检标本检查所确定的结果进行比较,对656例患有四种常见组织病理学类型原发性肺癌的患者的诊断准确性进行了评估。痰液和支气管抽吸物的细胞学检查以及支气管活检组织学检查所达到的诊断准确性超过85%。最不准确的诊断方法是经皮针吸活检(62%)。鳞状细胞癌和小细胞肿瘤通过所有四种检查均能得到准确诊断,但在大细胞癌和腺癌的诊断中出现了错误。近一半(43%)的大细胞癌患者后来被重新分类为鳞状细胞癌,在腺癌患者中,32%被预测为鳞状细胞癌,18%被预测为大细胞癌。我们认为,在个体患者的治疗以及纳入临床试验之前,这种预处理诊断的质量控制是必不可少的。